Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

STATEMENT BY THE BOARD OF DIRECTORS OF ALLENEX AB (PUBL) IN RELATION TO REVISED TERMS IN THE PUBLIC TAKEOVER OFFER FROM CAREDX, INC

Background CareDx, Inc (the “Bidder”) announced on 16 December 2015 a public takeover offer to the shareholders of Allenex AB (publ) (“Allenex”) to acquire all of the outstanding shares of Allenex (the “Offer”). With the exception of Midroc Invest AB, Fastpartner AB and Xenella Holding AB, the shareholders of Allenex were offered a cash consideration of 2.50 SEK per share (the “Cash Alternative”). As an alternative offer, a cash consideration of SEK 1.731 per share and 0.01298 shares in the Bidder per share in Allenex was offered (the “Mixed Alternative”), which at the time of the

MEDIVIR AB – FINANCIAL STATEMENT, JANUARY – DECEMBER 2015

Financial summary Fourth quarter 2015 (2014) · Net turnover totalled SEK 84.7 million (377.0 m), SEK 31.1 million (220.1 m) of which comprised royalties for simeprevir.    · Revenues from Medivir’s own pharmaceutical sales totalled SEK 53.1 million (156.6 m), of which SEK 2.7 million (103.1 m) derived from sales of OLYSIO® and SEK 50.4 million (53.5 m) from sales of other pharmaceuticals. · The loss after tax was SEK -45.2 million (147.3 m). · Basic and diluted earnings per share totalled SEK -1.56 (4.71) and SEK -1.54 (4.67), respectively. · The cash flow from operating

Hansa Medical AB (publ) - Year-End Report 2015

Several significant milestones reached in 2015January – December 2015 in summary – Highlights October – December · Hansa Medical’s shares began trading on Nasdaq Stockholm on November 2, 2015 · Data from the first patient in the ongoing US study with IdeS in highly sensitized patients presented at Hansa Medical’s Capital Markets Day on November 13, 2015, showed that one dose of IdeS effectively inactivates donor specific antibodies · Data published in Journal of Immunology shows that IdeS temporarily can silence B-cells, preventing B-cells from developing into antibody

Alfa Laval wins SEK 60 million energy-efficiency order in Russia

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has won an order to supply Alfa Laval compact heat exchangers to a refinery in Russia. The order, booked in the Energy& Process segment, has a value of approximately SEK 60 million and delivery is scheduled for 2016 and 2017.The order comprises the delivery of Alfa Laval compact heat exchangers for the preheating of crude oil in different steps of the refinery process. The innovative installation, where a complete crude oil process will be heated with welded heat exchangers instead of traditional

End Year Report 2015, 1 January – 31 December

Highlights Fourth quarter: 72 percent growth in revenue and a positive EBITDA of MSEK 23.4 · Group revenue increased by 72 percent to MSEK 172.5 (100.2). Online makes up 74 percent (58) of the group revenue. · Profitability improved considerably and EBITDA amounted to MSEK 23.4 (-6.5). EBIT amounted to MSEK 16.4 (-10.6). · The result after tax was MSEK 12.9 (-15.3), equivalent to SEK 0.63 (-1.13) per share after dilution and minority interests. · Online Gaming grew by 109 percent and EBITDA amounted to MSEK 15.4 (-4.3). · Yggdrasil Gaming grew by 696 percent and EBITDA

The Nomination Committee’s proposal to the Annual General Meeting 2016

STOCKHOLM, February 18th, 2016. Moberg Pharma AB announces that the company’s Nomination Committee has decided to present the following proposal to the Annual General Meeting 2016.The Nomination CommitteeThe Nomination Committee comprises of Per-Olof Edin (chairman) representing Östersjöstiftelsen, Katja Bergqvist representing Handelsbanken Fonder, Anders Rodebjer representing Wolco Invest och Mats Pettersson, chairman of the Board of Directors of the company. Chairman of the Annual General MeetingThe Nomination Committee proposes that Mats Pettersson is elected chairman of the

Growth and EBITDA margin for 2015 exceeding targets for the year and improved cash flows from operating activities

January – December 2015 Sales amounted to SEK 1,644.1 million (1,457.6), a sales growth of 12.8 percent. Operating profit before depreciation (EBITDA) amounted to SEK 274.6 million (246.3), corresponding to an EBITDA margin of 16.6 percent (16.8). EBITDA includes a capital loss of SEK 6.6 million related to the divestment of Opus Equipment. Cash flow from operating activities amounted to SEK 201.2 million (158.5). Profit for the period amounted to SEK 66.4 million (142.1). Earnings per share after dilution amounted to SEK 0.23 (0.53). The Board proposes a dividend of

Year-end report 2015

Fiscal year 2015, in brief · Highest profit and turnover in the history of the group · Net sales SEK 2,932 million (2,616) · Operating profit (EBIT) SEK 202 million (183) · Profit after financial items (EBT) SEK 212 million (187) · Equity ratio 58% (63) · Earnings per share after tax SEK 9.45 (8.34) · The Board proposes a dividend of SEK 2.25 (2.00) Fourth quarter, October – December 2015, in brief · The acquisition of Anton Kft. complements AQs customer base · Net sales SEK 803 million (703) · Operating profit (EBIT) SEK 55 million (65) · Profit

Ericsson 5G field trial gear achieves peak downlink throughput over 25 Gbps with MU-MIMO

· Ericsson 5G Radio Prototypes use MU-MIMO and beam tracking to deliver more than 25 Gbps throughput while ensuring reach and continuity of high-speed, high frequency, fully mobile connections · NTT DOCOMO and Korea Telecom executives witness powerful and commercially viable performance of  Ericsson 5G innovations for operator field trials · Live demonstration of 5G Radio Prototypes featured at MWC 2016 With 5G slated for commercialization in 2020, leading mobile operators are already planning 5G pre-standard field trials to test advanced technology features that can effectively

Proposal by the Nomination Committee regarding the Board of Directors of Cloetta AB

Cloetta’s Nomination Committee has informed the company of its proposal regarding new Board of Directors.The Nomination Committee proposes that the Board of Directors shall consist of seven directors, which is one more than currently. The Nomination Committee proposes re-election of the current directors Adriaan Nühn, Lottie Knutson, Mikael Svenfelt and Mikael Norman. Caroline Sundewall and Olof Svenfelt have declined re-election. Furthermore, the Nomination Committee proposes that Lilian Fossum Biner, Camilla Svenfelt and Hans Porat are elected as new directors. Lilian Fossum Biner is

Year-End Report Vigmed AB Holding (publ) January 1 – December 31, 2015

Financial information for the fourth quarter · Net Sales for the fourth quarter amounted to kSEK 1,116 (kSEK 685 in the fourth quarter 2014). · Operating profit in the fourth quarter for the Group amounted to MSEK -21.4 (MSEK -9.6). · Net income per weighted number of shares for the fourth quarter amounted to SEK -0.51 (SEK-0.26). · Cash flow from operating activities during the fourth quarter amounted to MSEK -6.1 (MSEK -4.2). · Cash flow from investing activities during the fourth quarter amounted to MSEK -1.8 (MSEK -3.5). · Cash flow from financing activities during

Year-end Report January-December 2015

"Bong has during the last year completely restructured the company and reduced the number of sites and personnel drastically in order to have a more lean and effective organization to be competitive in the tough envelope market. The rapid increase in paper prices from suppliers during the last year has successfully been passed on to the market to restore our margins. The turnaround is already seen in the figures and our goal to make profit on bottom line for 2016 is still valid", says Bong’s CEO Stéphane Hamelin.October – December 2015 · Net sales decreased with 9 percent to SEK 613

Year-end report Jan–Dec 2015

“Having joined Bisnode on 1 September, it is now my pleasure to present the first year-end report as CEO of Bisnode. As communicated in the Q3 2015 report we have in Q4 finalized the strategy process positioning ourselves as “pioneering Smart Data to enable our customers to make Smart Decisions.”FINANCIAL SUMMARY OCTOBER–DECEMBER 2015 • Revenue amounted to SEK 963m (954) • Organic revenue growth was 0.6 per cent (1.7) • Operating profit EBITA of SEK 119m (116) • Profit before tax totalled SEK 147m (27), which corresponds to earnings per share of SEK 0.9 (–0.2) FINANCIAL

The best financial results since 2008

Highlights · Agasti’s net income for the fourth quarter of 2015 was NOK 481 million compared to NOK -37 million in the same period last year. For the full year 2015, Agasti generated net income of NOK 517 million, compared to NOK -17 million in 2014. Sale of the operating activities · The sale of 34 per cent of the operating business to an affiliate of Blackstone is accounted for as a sale of the entire business resulting in a NOK 539 million tax free gain. The remaining 66 per cent share is recognized at fair value and accounted for as an investment in a joint venture

A year of positive volume and earnings growth, ending with the product approval in China

2015 ended with the long-awaited product approval in China and a first order from India. As a result of large deliveries in the fourth quarter we doubled the total volume of units shipped, compared with the year before. An additional order from C.R. Bard generated additional revenue and strengthened the result. A new licensing deal opened the door to a new area of application for our infection preventive technology.Fourth quarter (October-December 2015) · During the fourth quarter, a total of approx. 74,000 (8,000) BIP products were delivered, 100 % of which generated revenues. ·

President and CEO David Nuutinen comments on the results for the fourth quarter of 2015

Strong cash flow, decreased debt and proposed dividendCloetta stands strong2015 was a record year for Cloetta. All in all, sales were up by 6.8 per cent, of which 1.5 per cent was organic growth. This sales growth, combined with lower restructuring costs and good cost control, ena­bled us to boost our profitability yet again in 2015. Operating profit for the full year reached a record high of SEK 671m (577). Profit after tax was SEK 386m (242), which is equal to earnings per share of SEK 1.35 (0.84). And in spite of a completed acquisition, the net debt/EBITDA ratio has continued to

Head of HR Anna Vikström Persson has chosen to leave Sandvik

Anna Vikström Persson, Executive Vice President and Head of Group function Human Resources (HR), has decided to resign from her position, as of 1 June  2016. “Anna Vikström Persson has developed the HR organization and its operations in a significant way during challenging years for Sandvik. I have appreciated working with Anna and want to thank her for her valuable contributions. I wish her good luck in her future career” says Björn Rosengren, Sandvik’s President and CEO. Anna Vikström Persson has been in her current position since 2011. “I have had the opportunity to work for a

YEAR-END REPORT ORC GROUP HOLDING AB JANUARY 1 – DECEMBER 31, 2015

CONTINUED GROWTH IN THE FOURTH QUARTER AND LAUNCH OF ITIVITI· Operating revenue for the period from October to December 2015 was SEK 123,686k (101,425), an increase of 22% compared to the same period of 2014. Adjusted for foreign exchange effects, revenue was up by SEK 12,261k, most of which is attributable to the acquisition of Tbricks. After adjustment for foreign exchange effects, revenue for the fourth quarter rose marginally compared to the previous quarter. · Adjusted EBITDA was SEK 56,172k (46,598) and adjusted EBITDA-CAPEX was SEK 16,402k (17,670). Operating expenses and CAPEX,

Conversion of shares inNCC AB

In accordance with NCC’s Articles of Association, owners of Series A shares are entitled to request that their shares be converted to Series B shares. As a result of such conversion, the total number of voting rights in the company is reduced. In connection with conversion, the company is obligated, pursuant to the Swedish Financial Instruments Trading Act (1991:980), to disclose details of the change in this manner.At the request of Nordstjernan AB, 2,000,000 Series A shares have been converted to Series B shares. The total number of voting rights in the company subsequently amounts to 320,

Read original

Ericsson and NTT in technical collaboration on next generation cloud servers

· Ericsson and NTT  to jointly study benefits of hardware disaggregation · Study focuses on increased hardware utilization, efficiency and simplification · Ericsson's Hyperscale Datacenter System 8000 and cloud system software to support NTT's NetroSphere vision Ericsson (NASDAQ: ERIC) and Nippon Telegraph and Telephone Corporation (NTT), Japan's leading telecommunications operator, have initiated a collaboration focusing on the next generation of cloud servers. As part of the agreement, Ericsson and NTT will conduct a study aimed at determining how hardware disaggregation,

There are no items matching the current filter
There are no more items matching the current filter
Back to top